Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1739
2021 2906
2022 3376
2023 2712
2024 703

Text availability

Article attribute

Article type

Publication date

Search Results

10,164 results

Results by year

Filters applied: . Clear all
Quoted phrases not found in phrase index: "COVID-19 serotherapy", "incomplete* recover*", "long* recover*"
Page 1
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
Jarrot PA, Mirouse A, Ottaviani S, Cadiou S, Salmon JH, Liozon E, Parreau S, Michaud M, Terrier B, Gavand PE, Trefond L, Lavoiepierre V, Keraen J, Rekassa D, Bouldoires B, Weitten T, Roche D, Poulet A, Charpin C, Grobost V, Hermet M, Pallure M, Wackenheim C, Karkowski L, Grumet P, Rogier T, Belkefi N, Pestre V, Broquet E, Leurs A, Gautier S, Gras V, Gilet P, Holubar J, Sivova N, Schleinitz N, Durand JM, Castel B, Petrier A, Arcani R, Gramont B, Guilpain P, Lepidi H, Weiller PJ, Micallef J, Saadoun D, Kaplanski G. Jarrot PA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2334084. doi: 10.1080/21645515.2024.2334084. Epub 2024 Apr 2. Hum Vaccin Immunother. 2024. PMID: 38563792 Free PMC article.
We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) and to determine the clinical profile of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in COVID-19-vaccinated individuals …
We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) and to de …
The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis.
Stowe J, Lopez-Bernal J, Andrews N. Stowe J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2311969. doi: 10.1080/21645515.2024.2311969. Epub 2024 Feb 1. Hum Vaccin Immunother. 2024. PMID: 38299507 Free PMC article.
Acute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly follow
Acute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19
Hypophysitis after COVID-19 vaccination in a patient with Rathke's cleft cyst: A case report.
Yu Y, Zhou G, Du J, Zhu H, Guan H, Bi Y, Zhang D. Yu Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2297455. doi: 10.1080/21645515.2023.2297455. Epub 2024 Jan 4. Hum Vaccin Immunother. 2024. PMID: 38174857 Free PMC article.
A 59-y-old man presented with a loss of appetite after the first COVID-19 vaccination, which resolved spontaneously after 3 d. After the second COVID-19 vaccination, the symptoms including the loss of appetite, nausea, and vomiting reappe …
A 59-y-old man presented with a loss of appetite after the first COVID-19 vaccination, which resolved spontaneously aft …
Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors.
Pan T, Gallo ME, Donald KA, Webb K, Bath KG. Pan T, et al. Brain Behav Immun Health. 2024 Mar 18;38:100760. doi: 10.1016/j.bbih.2024.100760. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38586284 Free PMC article. Review.
Although many of these symptoms resolve following anti-inflammatory treatment, the long-term neurological and psychiatric sequelae of MIS-C are unknown. In this review, we will summarize two domains of the MIS-C disease course, 1) Neuroinflammation in the MIS …
Although many of these symptoms resolve following anti-inflammatory treatment, the long-term neurological and psychiatric sequelae
Cytotoxic lesion of corpus callosum after COVID-19 vaccination: case report.
Chang WL, Cheng CF, Lin SK. Chang WL, et al. Acta Neurol Taiwan. 2024 Jun 30;33(2):68-72. Acta Neurol Taiwan. 2024. PMID: 37848228
PURPOSE: Cytotoxic lesions of corpus callosum (CLOCCs) are associated with many disease entities. Serious neurological complications after coronavirus disease 2019 (COVID-19) vaccination are rare. ...Further autoimmune and hematological studies were no …
PURPOSE: Cytotoxic lesions of corpus callosum (CLOCCs) are associated with many disease entities. Serious neurological complications …
CASE REPORT: Fulminant acute hemorrhagic Leukoencephalitis (AHLE): A rare and ruinous outcome with cerebral herniation (COVID-19).
Safan AS, Noorain Z, Atta MA, Thekkoth R, Suliman AM, Fadlelmula A, Abdelatey M. Safan AS, et al. eNeurologicalSci. 2024 Apr 6;35:100499. doi: 10.1016/j.ensci.2024.100499. eCollection 2024 Jun. eNeurologicalSci. 2024. PMID: 38628435 Free PMC article.
In this report, we present a case of AHLE as a para-infectious sequel to COVID-19 in a young patient. CLINICAL PRESENTATION: We report a 30-year-old turkish patient with an initial presentation of upper respiratory tract infection due to COVID-19. Init …
In this report, we present a case of AHLE as a para-infectious sequel to COVID-19 in a young patient. CLINICAL PRESENTATION: W …
Has the first year of the COVID pandemic impacted the trends in obesity-related CVD mortality between 1999 and 2019 in the United States?
Qamar A, Abramov D, Bang V, Chew NW, Kobo O, Mamas MA. Qamar A, et al. Int J Cardiol Cardiovasc Risk Prev. 2024 Mar 14;21:200248. doi: 10.1016/j.ijcrp.2024.200248. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 38590764 Free PMC article.
BACKGROUND: During the covid-19 pandemic there was a marked rise in the number of cardiovascular deaths. Obesity is a well-known modifiable risk factor for cardiovascular disease and has been identified as a factor which leads to poorer covid-19 relate …
BACKGROUND: During the covid-19 pandemic there was a marked rise in the number of cardiovascular deaths. Obesity is a well-kno …
Hippocampal neurometabolic and structural changes from pre-to post-COVID-19: A case-series study.
Vints WAJ, Valatkevičienė K, Levin O, Weerasekera A, Jesmanas S, Kušleikienė S, Česnaitienė VJ, Himmelreich U, Verbunt JA, Ratai EM, Gleiznienė R, Masiulis N. Vints WAJ, et al. Magn Reson Imaging. 2024 Jun;109:249-255. doi: 10.1016/j.mri.2024.03.032. Epub 2024 Mar 22. Magn Reson Imaging. 2024. PMID: 38521366 Free article.
We examined within subject neurometabolic and structural brain alterations from pre-to post-COVID-19 in the hippocampal region of three elderly individuals (aged 63-68 years) who had a COVID-19 infection with mild symptoms. ...Our …
We examined within subject neurometabolic and structural brain alterations from pre-to post-COVID-19 in t …
Molecular cross-talk between long COVID-19 and Alzheimer's disease.
Pszczołowska M, Walczak K, Misków W, Antosz K, Batko J, Karska J, Leszek J. Pszczołowska M, et al. Geroscience. 2024 Jun;46(3):2885-2899. doi: 10.1007/s11357-024-01096-1. Epub 2024 Feb 23. Geroscience. 2024. PMID: 38393535 Free PMC article. Review.
The long COVID (coronavirus disease), a multisystemic condition following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the widespread problems. ...Multiple stu …
The long COVID (coronavirus disease), a multisystemic condition following severe acute respiratory
Covid-19 infection as a possible risk factor for longitudinally extensive transverse myelitis!
Koc ER, Turan ÖF, Mengüç B. Koc ER, et al. Int J Neurosci. 2024 Jun;134(2):193-196. doi: 10.1080/00207454.2022.2098731. Epub 2022 Jul 13. Int J Neurosci. 2024. PMID: 35791090
INTRODUCTION: There is limited data about the neurological effects of Covid-19 in infected patients. In this report, we present 2 LETM cases that are possibly associated with Covid-19 infection. ...CONCLUSION: The mechanism of LETM caused by …
INTRODUCTION: There is limited data about the neurological effects of Covid-19 in infected patients. In this report, we …
A proposal to apply brain injury recovery treatments for cognitive impairment in COVID-19 survivors.
Nouraeinejad A. Nouraeinejad A. Int J Neurosci. 2024 Jun;134(1):88-89. doi: 10.1080/00207454.2022.2084091. Epub 2022 Jun 5. Int J Neurosci. 2024. PMID: 35635529
In the meantime, there is mounting alarm regarding potential long-term outcomes of COVID-19, with descriptions of 'long COVID' symptoms keeping up into the chronic stage, which include 'brain fog'. ...The author proposes app …
In the meantime, there is mounting alarm regarding potential long-term outcomes of COVID-19, with descrip …
Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19.
McAlpine L, Zubair AS, Joseph P, Spudich S. McAlpine L, et al. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200244. doi: 10.1212/NXI.0000000000200244. Epub 2024 Apr 17. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38630952 Free article.
OBJECTIVES: To report a case-control study of new-onset small fiber neuropathy (SFN) after COVID-19 with invasive cardiopulmonary exercise testing (iCPET). ...DISCUSSION: Here, we present preliminary evidence that after COVID-19, S …
OBJECTIVES: To report a case-control study of new-onset small fiber neuropathy (SFN) after COVID-19 with invasiv …
Trajectories of Inflammatory Markers and Post-COVID-19 Cognitive Symptoms: A Secondary Analysis of the CONTAIN COVID-19 Randomized Trial.
Frontera JA, Betensky RA, Pirofski LA, Wisniewski T, Yoon H, Ortigoza MB. Frontera JA, et al. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200227. doi: 10.1212/NXI.0000000000200227. Epub 2024 Apr 16. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38626359 Free article. Clinical Trial.
BACKGROUND AND OBJECTIVES: Chronic systemic inflammation has been hypothesized to be a mechanistic factor leading to post-acute cognitive dysfunction after COVID-19. However, little data exist evaluating longitudinal inflammatory markers. ...Patients with pre …
BACKGROUND AND OBJECTIVES: Chronic systemic inflammation has been hypothesized to be a mechanistic factor leading to post-acute cognitive dy …
Intra and inter-rater remote assessment of bradykinesia in Parkinson's disease.
Luiz LMD, Marques IA, Folador JP, Andrade AO. Luiz LMD, et al. Neurologia (Engl Ed). 2024 May;39(4):345-352. doi: 10.1016/j.nrleng.2021.08.006. Neurologia (Engl Ed). 2024. PMID: 38616062 Free article.
However, this is only true when inter and intra-rater agreement are high. Recently, the Movement Disorder Society highlighted, during the COVID-19 pandemic, the need to develop and validate technologies for remote assessment of the motor status of peop …
However, this is only true when inter and intra-rater agreement are high. Recently, the Movement Disorder Society highlighted, …
Effectiveness and safety of immune response to SARS-CoV-2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta-analysis.
Li K, Xia Y, Ye H, Sun X, Shi B, Wu J. Li K, et al. Biomed Rep. 2024 Mar 19;20(5):78. doi: 10.3892/br.2024.1766. eCollection 2024 May. Biomed Rep. 2024. PMID: 38590946 Free PMC article.
The coronavirus disease 2019 (COVID-19) vaccination is the most effective way to prevent COVID-19. ...Adverse events such as fatigue, headache, and pain at the injection site may occur after COVID-19 vaccination but t …
The coronavirus disease 2019 (COVID-19) vaccination is the most effective way to prevent COVID-19. ...Adv …
Headache Associated with Coronavirus Disease 2019.
Sampaio Rocha-Filho PA. Sampaio Rocha-Filho PA. Neurol Clin. 2024 May;42(2):507-520. doi: 10.1016/j.ncl.2023.12.006. Epub 2024 Jan 12. Neurol Clin. 2024. PMID: 38575263 Review.
COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular diseases, rhinosinusitis, meningitis, and intracranial hypertension. ...To date, there are no clinical trials that have assessed th
COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular disea
Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates.
Saheb Sharif-Askari F, Ali Hussain Alsayed H, Saheb Sharif-Askari N, Saddik B, Al Sayed Hussain A, Halwani R. Saheb Sharif-Askari F, et al. Public Health. 2024 May;230:198-206. doi: 10.1016/j.puhe.2024.02.031. Epub 2024 Apr 3. Public Health. 2024. PMID: 38574425
OBJECTIVES: Long COVID is characterized by persistent symptoms lasting for 4 weeks or more following the acute infection with SARS-CoV-2. Risk factors for long COVID and the impact of pre-COVID vaccination and treatment duri …
OBJECTIVES: Long COVID is characterized by persistent symptoms lasting for 4 weeks or more following the acute infectio …
Sleep disorders, stress coping strategies and neurobehavioral aspects: an outlook on the impact of covid-19 in first-year resident physicians.
Teodoro M, Italia S, Giambò F, Costa C, Fenga C. Teodoro M, et al. Biomed Rep. 2024 Mar 6;20(5):72. doi: 10.3892/br.2024.1760. eCollection 2024 May. Biomed Rep. 2024. PMID: 38550243 Free PMC article.
The present study explored the relationship between sleep disorders, stress, coping strategies and neurobehavioral aspects among young physicians during the second wave of the COVID-19 pandemic. ...Further studies are performed to monitor long-term
The present study explored the relationship between sleep disorders, stress, coping strategies and neurobehavioral aspects among youn …
Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome.
González-Alvarez F, Estañol B, González-Hermosillo JA, Gómez-Pérez FJ, Tamez-Torres KM, Peña E, Cantú C, Chiquete E, Sifuentes-Osornio J, Alba-Lorenzo MDC, Celestino-Montelongo DA, Salazar-Calderón GE, Aceves Buendia JJ. González-Alvarez F, et al. J Hypertens. 2024 May 1;42(5):928-932. doi: 10.1097/HJH.0000000000003669. Epub 2024 Mar 8. J Hypertens. 2024. PMID: 38526146 Free PMC article.
The COVID-19 pandemic caused by the novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has emerged as a global public health concern and its sequels have barely started to outcrop. A good percentage of patients who s …
The COVID-19 pandemic caused by the novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV- …
10,164 results
You have reached the last available page of results. Please see the User Guide for more information.